Jansen Arthur S P, Schmidt E Donné, Voorn Pieter, Tilders Fred J H
Department of Medical Pharmacology, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Eur J Neurosci. 2003 Jan;17(2):298-306. doi: 10.1046/j.1460-9568.2003.02453.x.
Single administration of the cytokine interleukin-1 alpha (IL-1), or the psychostimulant amphetamine, enhanced adrenocorticotropin hormone and corticosterone responses to a stress challenge weeks later. This long-lasting hypothalamic-pituitary-adrenal (HPA)-sensitization is paralleled by an increase in electrically evoked release of noradrenaline in the paraventricular hypothalamic nucleus (PVN). We hypothesized that these functional changes may be associated with morphological plasticity of noradrenergic projections to the PVN, a parameter that shows high reproducibility. Specific alterations in relative (nor)adrenergic innervation density were studied by using dopamine-alpha-hydroxylase (DBH) as a marker. An image analysis system was used to detect changes in the relative DBH innervation density of the PVN. Groups of adult male rats were given IL-1 (10 microg/kg i.p.), amphetamine (5 mg/kg i.p.), or saline. Three weeks later, IL-1 and amphetamine primed rats showed enhanced adrenocorticotropin hormone and corticosterone responses to an amphetamine challenge. In another set of experiments, the relative DBH innervation density was measured in different PVN subnuclei at four rostro-caudal levels. Single administration of either IL-1 or amphetamine causes three weeks later a selective decrease in relative DBH innervation density in those subnuclei of the PVN that contain high numbers of corticotrophin-releasing hormone (CRH) producing neurons: the dorsal parvocellular and medial parvocellular PVN. We conclude that (1) long-lasting sensitization induced by single exposure to IL-1 and amphetamine induces specific pattern of neuroplastic changes in (nor)adrenergic innervation in the PVN and (2) reduction of relative DBH innervation density in CRH-rich areas is associated with paradoxical increase of electrically evoked release of (nor)adrenaline.
单次注射细胞因子白细胞介素 -1α(IL -1)或精神兴奋剂苯丙胺,数周后会增强促肾上腺皮质激素和皮质酮对压力挑战的反应。这种持久的下丘脑 - 垂体 - 肾上腺(HPA)致敏与下丘脑室旁核(PVN)中去甲肾上腺素电诱发释放的增加同时出现。我们推测这些功能变化可能与投射到PVN的去甲肾上腺素能神经纤维的形态可塑性有关,这一参数具有高度可重复性。通过使用多巴胺 -α- 羟化酶(DBH)作为标志物,研究了相对(去)甲肾上腺素能神经支配密度的特定变化。使用图像分析系统检测PVN相对DBH神经支配密度的变化。成年雄性大鼠分组接受IL -1(10微克/千克腹腔注射)、苯丙胺(5毫克/千克腹腔注射)或生理盐水。三周后,接受IL -1和苯丙胺预处理的大鼠对苯丙胺挑战显示出增强的促肾上腺皮质激素和皮质酮反应。在另一组实验中,在四个 rostro - 尾端水平测量了不同PVN亚核中的相对DBH神经支配密度。单次注射IL -1或苯丙胺三周后,在PVN中含有大量促肾上腺皮质激素释放激素(CRH)产生神经元的亚核:背侧小细胞和内侧小细胞PVN中,相对DBH神经支配密度出现选择性降低。我们得出结论:(1)单次暴露于IL -1和苯丙胺诱导的持久致敏在PVN中(去)甲肾上腺素能神经支配中诱导了特定模式的神经可塑性变化;(2)富含CRH区域中相对DBH神经支配密度的降低与(去)甲肾上腺素电诱发释放的反常增加有关。